With regards to the functional significance of the activation of the EF pathway following bariatric surgery, recent investigations of COVID-19 have suggested the EF response as the source of de novo autoimmunity in patients with severe disease, specifically anti-nuclear antigen (ANA) and anti-carbamylated protein antibodies were detected [21]. The gene discussed is BTG3; the disease is COVID-19.